BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38890532)

  • 1. Molecular pathology markers of FTD and ALS in blood extracellular vesicles.
    Nat Med; 2024 Jun; 30(6):1545-1546. PubMed ID: 38890532
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS.
    Chatterjee M; Özdemir S; Fritz C; Möbius W; Kleineidam L; Mandelkow E; Biernat J; Doğdu C; Peters O; Cosma NC; Wang X; Schneider LS; Priller J; Spruth E; Kühn AA; Krause P; Klockgether T; Vogt IR; Kimmich O; Spottke A; Hoffmann DC; Fliessbach K; Miklitz C; McCormick C; Weydt P; Falkenburger B; Brandt M; Guenther R; Dinter E; Wiltfang J; Hansen N; Bähr M; Zerr I; Flöel A; Nestor PJ; Düzel E; Glanz W; Incesoy E; Bürger K; Janowitz D; Perneczky R; Rauchmann BS; Hopfner F; Wagemann O; Levin J; Teipel S; Kilimann I; Goerss D; Prudlo J; Gasser T; Brockmann K; Mengel D; Zimmermann M; Synofzik M; Wilke C; Selma-González J; Turon-Sans J; Santos-Santos MA; Alcolea D; Rubio-Guerra S; Fortea J; Carbayo Á; Lleó A; Rojas-García R; Illán-Gala I; Wagner M; Frommann I; Roeske S; Bertram L; Heneka MT; Brosseron F; Ramirez A; Schmid M; Beschorner R; Halle A; Herms J; Neumann M; Barthélemy NR; Bateman RJ; Rizzu P; Heutink P; Dols-Icardo O; Höglinger G; Hermann A; Schneider A
    Nat Med; 2024 Jun; 30(6):1771-1783. PubMed ID: 38890531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging roles of microRNAs in the pathogenesis of frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) spectrum disorders.
    Gascon E; Gao FB
    J Neurogenet; 2014; 28(1-2):30-40. PubMed ID: 24506814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common Molecular Pathways in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
    Weishaupt JH; Hyman T; Dikic I
    Trends Mol Med; 2016 Sep; 22(9):769-783. PubMed ID: 27498188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.
    Dewan R; Chia R; Ding J; Hickman RA; Stein TD; Abramzon Y; Ahmed S; Sabir MS; Portley MK; Tucci A; Ibáñez K; Shankaracharya FNU; Keagle P; Rossi G; Caroppo P; Tagliavini F; Waldo ML; Johansson PM; Nilsson CF; ; ; ; ; ; ; ; ; Rowe JB; Benussi L; Binetti G; Ghidoni R; Jabbari E; Viollet C; Glass JD; Singleton AB; Silani V; Ross OA; Ryten M; Torkamani A; Tanaka T; Ferrucci L; Resnick SM; Pickering-Brown S; Brady CB; Kowal N; Hardy JA; Van Deerlin V; Vonsattel JP; Harms MB; Morris HR; Ferrari R; Landers JE; Chiò A; Gibbs JR; Dalgard CL; Scholz SW; Traynor BJ
    Neuron; 2021 Feb; 109(3):448-460.e4. PubMed ID: 33242422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SnapShot: Genetics of ALS and FTD.
    Guerreiro R; Brás J; Hardy J
    Cell; 2015 Feb; 160(4):798-798.e1. PubMed ID: 25679767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Amyotrophic lateral sclerosis and frontotemporal dementia: overlapping characteristics].
    Raaphorst J; Grupstra HF; Linssen WH; van Swieten JC; Schmand B; de Visser M
    Ned Tijdschr Geneeskd; 2010; 154():A631. PubMed ID: 20178658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
    Murray ME; DeJesus-Hernandez M; Rutherford NJ; Baker M; Duara R; Graff-Radford NR; Wszolek ZK; Ferman TJ; Josephs KA; Boylan KB; Rademakers R; Dickson DW
    Acta Neuropathol; 2011 Dec; 122(6):673-90. PubMed ID: 22083254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SQSTM1 mutations in French patients with frontotemporal dementia or frontotemporal dementia with amyotrophic lateral sclerosis.
    Le Ber I; Camuzat A; Guerreiro R; Bouya-Ahmed K; Bras J; Nicolas G; Gabelle A; Didic M; De Septenville A; Millecamps S; Lenglet T; Latouche M; Kabashi E; Campion D; Hannequin D; Hardy J; Brice A;
    JAMA Neurol; 2013 Nov; 70(11):1403-10. PubMed ID: 24042580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofilament light chain in FTD is elevated not only in cerebrospinal fluid, but also in serum.
    Wilke C; Preische O; Deuschle C; Roeben B; Apel A; Barro C; Maia L; Maetzler W; Kuhle J; Synofzik M
    J Neurol Neurosurg Psychiatry; 2016 Nov; 87(11):1270-1272. PubMed ID: 27188986
    [No Abstract]   [Full Text] [Related]  

  • 11. [Overlapping features of frontotemporal dementia and amyotrophic lateral sclerosis].
    Lillo P; Matamala JM; Valenzuela D; Verdugo R; Castillo JL; Ibáñez A; Slachevsky A
    Rev Med Chil; 2014 Jul; 142(7):867-79. PubMed ID: 25378006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics insight into the amyotrophic lateral sclerosis/frontotemporal dementia spectrum.
    Ji AL; Zhang X; Chen WW; Huang WJ
    J Med Genet; 2017 Mar; 54(3):145-154. PubMed ID: 28087719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 mice.
    McCann EP; Fifita JA; Grima N; Galper J; Mehta P; Freckleton SE; Zhang KY; Henden L; Hogan AL; Chan Moi Fat S; Wu SS; Jagaraj CJ; Berning BA; Williams KL; Twine NA; Bauer D; Piguet O; Hodges J; Kwok JBJ; Halliday GM; Kiernan MC; Atkin J; Rowe DB; Nicholson GA; Walker AK; Blair IP; Yang S
    J Neurol Neurosurg Psychiatry; 2020 Feb; 91(2):162-171. PubMed ID: 31690696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raman spectroscopy reveals biochemical differences in plasma derived extracellular vesicles from sporadic Amyotrophic Lateral Sclerosis patients.
    Morasso CF; Sproviero D; Mimmi MC; Giannini M; Gagliardi S; Vanna R; Diamanti L; Bernuzzi S; Piccotti F; Truffi M; Pansarasa O; Corsi F; Cereda C
    Nanomedicine; 2020 Oct; 29():102249. PubMed ID: 32599162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Making connections: pathology and genetics link amyotrophic lateral sclerosis with frontotemporal lobe dementia.
    Fecto F; Siddique T
    J Mol Neurosci; 2011 Nov; 45(3):663-75. PubMed ID: 21901496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and neuropathological features of ALS/FTD with TIA1 mutations.
    Hirsch-Reinshagen V; Pottier C; Nicholson AM; Baker M; Hsiung GR; Krieger C; Sengdy P; Boylan KB; Dickson DW; Mesulam M; Weintraub S; Bigio E; Zinman L; Keith J; Rogaeva E; Zivkovic SA; Lacomis D; Taylor JP; Rademakers R; Mackenzie IRA
    Acta Neuropathol Commun; 2017 Dec; 5(1):96. PubMed ID: 29216908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p.
    Hsiung GY; DeJesus-Hernandez M; Feldman HH; Sengdy P; Bouchard-Kerr P; Dwosh E; Butler R; Leung B; Fok A; Rutherford NJ; Baker M; Rademakers R; Mackenzie IR
    Brain; 2012 Mar; 135(Pt 3):709-22. PubMed ID: 22344582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered serum protein levels in frontotemporal dementia and amyotrophic lateral sclerosis indicate calcium and immunity dysregulation.
    Katzeff JS; Bright F; Lo K; Kril JJ; Connolly A; Crossett B; Ittner LM; Kassiou M; Loy CT; Hodges JR; Piguet O; Kiernan MC; Halliday GM; Kim WS
    Sci Rep; 2020 Aug; 10(1):13741. PubMed ID: 32792518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UBQLN2/P62 cellular recycling pathways in amyotrophic lateral sclerosis and frontotemporal dementia.
    Fecto F; Siddique T
    Muscle Nerve; 2012 Feb; 45(2):157-62. PubMed ID: 22246868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features.
    Shaw MP; Higginbottom A; McGown A; Castelli LM; James E; Hautbergue GM; Shaw PJ; Ramesh TM
    Acta Neuropathol Commun; 2018 Nov; 6(1):125. PubMed ID: 30454072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.